background
wheez
earli
life
common
disord
reason
underli
differ
wheez
phenotyp
still
unclear
aim
studi
analys
potenti
correl
risk
develop
recurr
wheez
presenc
specif
polymorph
gene
regul
immun
system
function
studi
rel
import
associ
differ
virus
genet
polymorph
caus
recurr
episod
studi
involv
otherwis
healthi
infant
admit
hospit
first
episod
wheez
subsequ
experienc
recurr
episod
ageand
sexmatch
subject
without
histori
respiratori
problem
randomli
select
attend
outpati
clinic
studi
period
studi
subject
follow
two
year
singl
nucleotid
polymorph
snp
candid
gene
genotyp
whole
blood
use
abi
prism
ht
fast
realtim
instrument
result
associ
significantli
increas
risk
develop
wheez
p
p
p
p
wherea
associ
significantli
reduc
risk
p
p
associ
significantli
increas
risk
develop
recurr
wheez
p
p
p
wherea
associ
significantli
reduc
risk
p
interestingli
studi
geneenviron
interact
show
rhinoviru
significantli
associ
recurr
wheez
presenc
g
odd
ratio
confid
interv
ci
p
ci
p
conclus
studi
show
clear
relationship
risk
wheez
polymorph
gene
involv
immun
respons
although
studi
need
confirm
result
find
may
use
earli
identif
children
highest
risk
develop
recurr
episod
possibl
subsequ
asthma
background
wheez
earli
life
common
disord
longitudin
birth
cohort
studi
estim
cumul
preval
preschool
year
approxim
case
wheez
infant
young
children
associ
viral
acut
lower
respiratori
tract
infect
lrti
mainli
due
respiratori
syncyti
viru
rsv
rhinoviru
rv
less
frequent
virus
human
metapneumoviru
bocaviru
parainfluenza
viru
children
experi
one
episod
wheez
small
number
infrequ
recurr
usual
affect
signific
respiratori
problem
later
life
howev
substanti
number
children
experi
wheez
everi
time
suffer
respiratori
viral
infect
subject
develop
asthma
school
age
reason
differ
wheez
phenotyp
still
unclear
number
clinic
epidemiolog
studi
shown
sever
individu
episod
risk
recurr
risk
develop
asthma
frequent
associ
presenc
atopi
particular
clinic
environment
condit
prematur
exposur
tobacco
smoke
microbiolog
studi
shown
virus
potenti
caus
sever
recurr
case
rsv
rv
frequent
identifi
respiratori
secret
subject
recurr
wheez
howev
analysi
data
collect
studi
possibl
relationship
viral
lrti
wheez
shown
even
absenc
known
risk
factor
consider
number
children
experi
sever
andor
frequent
recur
infect
wheez
develop
asthma
adolesc
suggest
alter
innat
adapt
immun
respons
viral
lrti
may
favour
virusinduc
airway
dysfunct
lead
sever
sign
symptom
longlast
chang
anatom
histolog
characterist
respiratori
tree
predispos
recurr
develop
asthma
number
studi
indic
risk
seem
close
associ
genet
polymorph
gene
encod
factor
involv
innat
adapt
immun
howev
littl
known
immun
respons
mechan
modifi
genet
defect
play
major
role
condit
suscept
wheez
done
increas
host
defenc
case
precis
identif
specif
genet
variant
involv
immun
associ
increas
risk
lrti
recurr
wheez
forese
applic
pediatr
prevent
medicin
vaccin
develop
expect
analys
method
reduc
neg
impact
genet
defect
innat
adapt
immun
consider
consequ
aim
studi
analys
potenti
correl
risk
develop
recurr
lrti
wheez
presenc
specif
polymorph
gene
regul
immun
system
function
studi
rel
import
associ
differ
virus
genet
polymorph
caus
recurr
episod
studi
carri
pediatr
highli
intens
care
unit
fondazion
ircc
ca
granda
ospedal
maggior
policlinico
milan
itali
novemb
septemb
protocol
approv
ethic
committe
fondazion
ircc
ca
granda
ospedal
maggior
policlinico
written
inform
consent
obtain
parent
legal
guardian
patient
enrol
studi
initi
involv
otherwis
healthi
infant
age
month
admit
hospit
first
episod
rti
wheez
diagnos
basi
wellestablish
criteria
particular
infant
clinic
evid
respiratori
tract
infect
fever
stuf
runni
nose
sneez
cough
accompani
wheez
ie
continu
highpitch
sound
music
qualiti
emit
chest
expir
enrol
exclus
criteria
prematur
birth
presenc
chronic
diseas
increas
risk
complic
respiratori
infect
ie
chronic
pulmonari
cardiovascular
system
disord
chronic
metabol
diseas
neoplasia
kidney
liver
dysfunct
hemoglobinopathi
immunosuppress
genet
neurolog
disord
select
refus
particip
upon
enrol
demograph
characterist
medic
histori
infant
systemat
record
use
standardis
written
questionnair
specimen
detect
respiratori
virus
taken
use
flexibl
pernas
flock
swab
ml
univers
trasport
medium
kit
cat
copan
italia
brescia
itali
enrol
ml
whole
blood
sampl
also
obtain
genet
studi
enrol
children
follow
month
order
monitor
incid
new
wheez
episod
end
parent
ask
bring
children
centr
control
visit
everi
month
everi
time
children
experienc
febril
episod
accompani
symptom
suggest
lrti
cough
tachypnea
grunt
chest
indraw
feed
difficulti
airway
nois
irrit
poor
sleep
parent
also
ask
complet
diari
record
children
clinic
problem
administr
drug
includ
antipyret
overcom
problem
possibl
underreport
wheez
episod
famili
systemat
telephon
weekli
verifi
children
statu
medic
examin
plan
monthli
examin
follow
develop
febril
episod
carri
train
investig
se
ct
use
standardis
questionnair
visit
detail
medic
event
occur
sinc
previou
visit
record
children
underw
complet
physic
examin
control
ageand
gendermatch
healthi
subject
neg
histori
lrti
wheez
respiratori
problem
first
two
year
life
randomli
select
basi
computergener
randomis
list
attend
outpati
clinic
clinic
control
minor
surgic
procedur
studi
period
although
control
clinic
follow
sinc
age
studi
patient
ml
whole
blood
sampl
genet
studi
obtain
age
month
order
sure
suffer
wheez
episod
first
year
life
viral
rna
dna
extract
respiratori
secret
mean
nuclisen
easymag
autom
extract
system
craponn
franc
test
use
luminex
x
tag
respiratori
viru
panel
fast
assay
luminex
molecular
diagnost
inc
toronto
canada
order
detect
influenza
viru
subtyp
influenza
b
viru
rsva
b
adenoviru
human
metapneumoviru
coronavirus
enterovirusrv
human
bocaviru
accord
manufactur
instruct
enterovirusrvposit
sampl
retest
mean
realtim
polymeras
chain
reaction
rtpcr
assay
use
onestep
iagpathid
rtpcr
kit
appli
biosystem
foster
citi
ca
primer
probe
sequenc
report
lu
et
al
order
identifi
type
rv
thirtythre
candid
gene
singl
nucleotid
polymorph
snp
select
analysi
includ
gene
involv
immun
regul
pathogenesi
inflamm
wheez
select
gene
encod
transcript
chuk
ikikb
jun
transduct
factor
regul
cell
activ
pattern
recognit
receptor
proinflammatori
cytokin
relat
receptor
antiinflammatori
cytokin
cytokin
regul
lymphoid
cell
surviv
chemokin
regul
ige
product
collectin
protein
respons
acut
respons
bacteri
lipopolysaccharid
lbp
growth
factor
ngf
vegfa
protein
involv
structur
mainten
chromosom
spermatogenesisassoci
serinerich
thromboxan
receptor
adrenerg
beta
surfac
receptor
locat
autosom
case
snp
function
variant
tag
snp
characteris
intern
hapmap
project
studi
snp
involv
caus
determin
sever
outcom
wheez
experiment
anim
human
previous
found
associ
increas
risk
develop
asthma
abnorm
immun
respons
investig
gene
snp
list
tabl
dna
extract
use
masterpur
dna
purif
kit
epicentr
madison
fl
accord
manufactur
instruct
final
elut
volum
purif
extract
dna
quantifi
use
picogreen
reagent
life
technolog
monza
itali
infinit
pro
fluorimet
tecan
italia
cernusco
sul
naviglio
itali
follow
nucleic
acid
purif
procedur
sampl
store
use
fortyseven
snp
gene
genotyp
use
custom
array
microfluid
card
genotyp
system
abi
appli
biosystem
foster
citi
ca
pcr
amplif
allel
detect
mean
endpoint
analysi
use
sd
taqman
genotyp
softwar
appli
biosystem
foster
citi
ca
data
enter
progeni
databas
progeni
softwar
llc
south
bend
gener
dataset
analysi
sampl
size
subject
two
group
achiev
power
alpha
detect
unadjust
odd
ratio
assum
control
group
proport
children
given
polymorph
allel
given
gene
test
statist
use
twosid
mantelhaenszel
test
categor
data
compar
group
use
conting
tabl
analysi
fisher
exact
test
appropri
continu
data
analys
use
twosid
student
ttest
check
normal
distribut
base
shapirowilk
statist
twosid
wilcoxon
ranksum
test
otherwis
genotyp
frequenc
determin
mean
direct
count
order
investig
hardyweinberg
equilibrium
hwe
expect
number
genotyp
compar
observ
number
potenti
deviat
assess
use
chisquar
likelihood
ratio
test
appropri
ageadjust
confid
interv
ci
calcul
order
measur
associ
select
snp
suscept
wheez
compar
children
wheez
control
suscept
recurr
wheez
compar
children
experienc
one
episod
wheez
data
control
multipl
test
use
fals
discoveri
rate
method
benjaminihochberg
nineteen
children
includ
group
patient
lost
studi
period
parent
refus
return
everi
month
studi
center
adequ
collect
inform
regard
respiratori
infect
children
consequ
patient
consid
compar
control
tabl
summaris
demograph
clinic
characterist
studi
popul
gender
age
distribut
similar
children
wheez
control
children
nonrecurr
recurr
wheez
subject
caucasian
born
term
durat
breastfeed
use
pacifi
least
one
older
sibl
similar
group
exposur
cigarett
smoke
high
ige
level
famili
histori
atopi
significantli
frequent
among
children
wheez
control
p
p
p
famili
histori
atopi
significantli
frequent
among
children
recurr
nonrecurr
wheez
p
select
snp
allel
frequenc
similar
children
type
wheez
control
similar
children
nonrecurr
recurr
wheez
examin
snp
present
studi
popul
tabl
show
snp
genotyp
frequenc
significantli
differ
children
wheez
control
tabl
significantli
differ
children
nonrecurr
wheez
recurr
wheez
associ
significantli
increas
risk
develop
wheez
p
p
p
p
wherea
associ
significantli
reduc
risk
p
p
associ
significantli
increas
risk
develop
recurr
wheez
p
p
p
wherea
associ
significantli
reduc
risk
p
differ
genotyp
frequenc
found
tabl
show
distribut
viral
infect
children
nonrecurr
recurr
wheez
rsv
frequent
detect
pathogen
major
studi
show
genet
polymorph
seem
play
substanti
role
condit
risk
wheez
young
children
viral
lrti
suscept
develop
wheez
seem
greater
children
snp
vegfa
ikbkb
gene
associ
vegfa
gene
surpris
factor
encod
play
import
role
immun
previous
associ
bronchial
obstruct
one
import
chemotact
factor
leukocyt
recruit
activ
lung
control
prevent
excess
tissu
injuri
possibl
damag
system
effect
snp
evalu
studi
previous
found
significantli
associ
sever
rsv
bronchiol
recurr
wheez
episod
also
found
high
concentr
cord
blood
significantli
associ
persist
wheez
age
one
year
import
condit
suscept
wheez
seem
confirm
find
genet
polymorph
associ
risk
wheez
suscept
recurr
episod
vegfa
major
regul
angiogenesi
enhanc
vascular
permeabl
seem
induc
airway
inflamm
airway
remodel
patient
asthma
high
vegfa
level
found
subject
chronic
pulmonari
diseas
certain
kind
pneumonia
found
significantli
higher
serum
children
mycoplasma
pneumonia
infect
wheez
healthi
control
protein
belong
collectin
famili
import
innat
immun
system
recognis
mannos
nacetylglucosamin
mani
microorgan
capabl
activ
classic
complement
pathway
defici
gene
associ
suscept
autoimmun
infecti
diseas
welldefin
weak
associ
found
snp
asthma
atopi
children
previou
report
associ
ikbkb
gene
increas
suscept
wheez
gene
encod
ikb
kinas
also
known
compon
ikknuclear
factor
pathway
number
primari
immunodefici
leas
increas
risk
infect
autoimmun
caus
impair
axi
ikk
requir
signal
associ
neutrophilia
pulmonari
inflamm
level
found
higher
patient
asthma
possibl
snp
ikbkb
could
lead
increas
risk
wheez
reduc
risk
develop
wheez
found
children
nfkbib
snp
snp
associ
reduc
risk
develop
recurr
wheez
data
concern
nfkbib
factor
involv
innat
immun
conflict
collect
daley
et
al
sharma
et
al
studi
larg
number
snp
found
children
genet
abnorm
nfkbib
viral
respiratori
infect
earli
life
increas
risk
develop
asthma
data
concern
line
find
author
other
factor
play
essenti
role
function
regulatori
cell
control
immun
respons
borrego
et
al
report
comparison
healthi
children
express
diminish
wheezi
subject
high
risk
asthma
thu
suggest
impair
express
may
play
role
reduc
bronchial
obstruct
howev
ermer
et
al
found
significantli
frequent
children
wheez
healthi
control
recognis
dsrna
deriv
respiratori
virus
activ
nuclear
increas
signal
cell
transform
airway
inflamm
asthma
cytokin
particip
process
modul
respons
airway
epithelium
dendrit
cell
context
rv
infect
bind
viral
dsrna
initi
proinflammatori
signal
pathway
lead
airway
inflamm
hyperrespons
contrari
find
nuolivirta
et
al
found
associ
increas
risk
bronchiol
significantli
frequent
patient
recurr
wheez
moreov
daley
et
al
document
posit
associ
snp
atop
asthma
discrep
may
due
differ
ethnic
gener
characterist
studi
popul
differ
wheez
phenotyp
found
recurr
wheez
first
year
viral
lrti
recurr
wheez
age
six
year
distinct
entiti
specif
immunolog
genet
characterist
also
possibl
result
influenc
genegen
interact
andor
differ
hwe
find
regard
associ
snp
geneenviron
interact
also
partial
differ
previou
studi
expect
rsv
frequent
detect
pathogen
studi
frequenc
significantli
higher
children
nonrecurr
wheez
recurr
episod
may
explain
fact
vast
major
patient
affect
rsv
infect
differ
distribut
genet
polymorph
children
recurr
nonrecurr
episod
due
rsv
infect
hand
rv
infect
significantli
associ
recurr
wheez
presenc
snp
gene
gene
encod
alpha
chain
receptor
type
transmembran
protein
bind
thu
regul
ige
antibodi
product
b
cell
encod
protein
also
bind
cell
promot
differenti
cell
allel
variat
gene
associ
atopi
allerg
clinic
manifest
furthermor
rv
infect
major
caus
asthma
exacerb
rv
also
repeatedli
detect
patient
stabl
asthma
number
studi
shown
abnorm
innat
immun
respons
virus
patient
asthma
particularli
defici
product
ifn
iii
find
snp
gene
associ
recurr
wheez
episod
rv
lrti
contribut
explain
complic
could
follow
rv
infect
similar
conclus
drawn
relat
associ
snp
gene
wheez
recurr
children
rv
infect
data
extend
find
szczepankiewicz
et
al
observ
associ
asthma
gene
polymorph
suggest
genet
variant
gene
involv
regul
neurogen
inflamm
may
contribut
asthma
possibl
via
enhanc
ngf
express
activ
mapk
signal
pathway
studi
limit
first
number
enrol
subject
rel
small
studi
larger
pediatr
popul
would
increas
probabl
statist
associ
found
us
repres
true
biolog
differ
reduc
risk
fals
posit
result
secondli
although
consider
number
studi
gene
snp
probabl
less
number
gene
genet
variat
actual
involv
regul
mechan
play
role
condit
suscept
infect
develop
wheez
final
evalu
effect
common
environment
exposur
associ
gene
immun
pathway
wheez
suggest
environment
exposur
may
modifi
effect
genet
variant
diseas
suscept
analysi
geneenvironment
interact
necessari
draw
definit
conclus
find
show
clear
relationship
risk
wheez
polymorph
gene
involv
immun
respons
despit
conclus
indic
genet
play
import
role
condit
wheez
develop
howev
given
conflict
literatur
larg
studi
need
order
establish
real
associ
wheez
develop
genet
variat
